Influence of Dibutyl Phthalate on Dermal Sensitization to Fluorescein Isothiocyanate. DEARMAN, R. J., CUMBERBATCH, M., HIL-TON, J., CLOWES, H. M., FIELDING, I., HEYLINGS, J. R., AND KIMBER, I. (1996) . Fundam. Appl. Toxicol. 33, [24] [25] [26] [27] [28] [29] [30] What limited evidence there is indicates that the formulation in which a chemical allergen is encountered on the skin can have a marked impact upon the induction of cutaneous immune responses and the subsequent development of contact sensitization. The purpose of the present investigations was to examine further this phenomenon by analysis of the influence of dibutyl phthalate (DBP) on dermal sensitization to fluorescein isothiocyanate (FITC), a skin sensitizing fluorochrome. Addition of DBP augmented very substantially, in a dose-dependent fashion, the ability of topically applied FITC to stimulate proliferative responses in mice by draining lymph node cells (LNC), a correlate of skin sensitizing potential. Under these conditions, exposure of mice to DBP alone failed to elicit significant LNC responses. The influence of DBP on the accumulation of dendritic cells (DC) induced by FITC was examined also. Although 10% DBP had little effect on the numbers of DC found within draining nodes 18 hr following exposure of mice to FITC, the phthalate did result in a very substantial increase in the frequency of lymph node DC bearing detectable antigen (FITC + DC). Furthermore, in the presence of DBP the median amount of FITC associated with antigen-bearing DC was higher. In vitro skin absorption studies indicated that DBP was associated with a small increase in percutaneous absorption of FITC. Collectively these data demonstrate that the vehicle formulation can exert a marked influence on dermal sensitization and that one mechanism which may be relevant is the increased acquisition of antigen by DC, associated possibly with altered penetration of the allergen into or through the skin, c i996SodetyofTmdco4ogy
Allergic contact dermatitis is a common occupational health problem and there are available both guinea pig and mouse predictive test methods for the identification of chemicals that have the potential to cause skin sensitization (Andersen and Maibach, 1985; Gad, 1994; Kjmber era/., 1994) . Such methods are designed and conducted usually for the purposes of hazard identification, with the emphasis being upon assessment of the sensitizing activity of discrete chemicals. It is apparent, however, that topical exposure to chemicals frequently occurs in the context of mixtures and formu-0272-O59Q/96SI8 0O 24 Copyright C 1996 by the Society of Toxicology All rights of reproduction in any form reserved.
lations. What evidence there is suggests that the way in which a chemical is delivered to the skin can have a substantial impact upon whether and to what extent contact sensitization is induced. In 1966 KJigman described investigations in which various strategies were used to modify the skin sensitizing activity in humans of several well-known contact allergens. One conclusion drawn was that mild inflammation at the site of exposure increases the opportunity for contact sensitization. It was found that, in most instances, coadministration of allergen with the skin irritant sodium lauryl sulfate (SLS) increased the incidence of sensitization (Kligman, 1966) . More recently we have demonstrated that SLS may enhance skin sensitization to chemical allergens in mice also (Cumberbatch et al., 1993) . While it has been assumed that slight irritation will facilitate access of the chemical into and through the skin, this is not necessarily the case. It was observed in mice that enhanced responsiveness to the contact allergen 2,4-dinitrochlorobenzene (DNCB) induced by coapplication with SLS could not be reconciled in terms of accelerated or increased percutaneous absorption; the alternative explanation is that SLS served to stimulate further the accumulation of immunostimulatory dendritic cells (DC) in draining lymph nodes (Cumberbatch et al, 1993) .
The purpose of the present investigations was to examine in greater detail the mechanisms through which formulation may influence cutaneous immune function and the integrity of skin sensitization. To this end, the effects of dibutyl phthalate (DBP) (a chemical that lacks contact allergic potential) on responses stimulated in mice following topical application of the skin sensitizing fluorochrome fluorescein isothiocyanate (FITC) have been investigated. The influence of DBP on the absorption of FITC, the induction by FITC of lymph node activation, and DC accumulation in draining nodes has been measured.
MATERIALS AND METHODS

Lymph node cell proliferation.
Draining lymph node cell (LNC) proliferative responses were measured following topical exposure of mice to chemical allergen (FITC or DNCB) or to the relevant formulation alone on the dorsum of both ears. Groups of mice (n = 4) received 25 fx\ of chemical in acetone, acetone supplemented with various concentrations of DBP. or an equal volume of either acetone or acetone containing DBP alone daily for 3 consecutive days. Three days following the initiation of exposure, mice were injected intravenously via the tail vein with 250 /j| of phosphatebuffered saline (PBS) containing 20 piCi of [ 3 H]methyl thymidine ( 3 HTdR; specific activity 2 Ci/mmol; Amersham International, Amersham, Buckinghamshire, UK). Mice were killed 5 hr later and the draining auricular lymph nodes excised and pooled for each experimental group. A singlecell suspension of LNC was prepared by mechanical disaggregation through 200-mesh stainless steel gauze, washed twice with PBS, and precipitated with 5% trichloroacetic acid (TCA) at 4°C. Pellets were resuspended 12 hr later in 1 ml TCA and 10 ml of scintillation fluid (Optiphase, LKB, Sweden) was added. Incorporation of 3 HTdR was measured by ^-scintillation counting and the results were expressed as disintegrations per minute (dpm) per node for each experimental group.
Dendritic cell accumulation. The accumulation of DC in lymph nodes draining the site of exposure was measured according to a method described previously (Kinnaird et al, 1989) . Auricular lymph nodes were excised 18 hr following topical exposure of mice (n = 10) on the dorsum of both ears to 25 /JI of chemical allergen in acetone or acetone supplemented with various concentrations of DBP or to an equal volume of the relevant formulation alone Further groups of mice were untreated. Nodes were pooled for each group and a single-cell suspension of LNC was prepared as described above. LNC were washed and resuspended in RPMI 1640 growth medium (Gibco Ltd., Paisley, Renfrewshire, UK) supplemented with 25 mM Hepes, 400 /Jg/ml ampicillin, 400 /ig/ml streptomycin, and 10% heatinactivated fetal calf serum (RPMI-FCS). Viable cell counts were performed by exclusion of 0.5% trypan blue and the cell concentration adjusted to 5 X 10 6 cells/ml in RPMI-FCS Populations enriched for and depleted of DC were prepared by buoyant density centnfugation. Metrizamide (2 ml; 14.5% in RPMI-FCS; Nygaard, Oslo, Norway) was layered gently under 8 ml of LNC and the gradients centrifuged at 600g for 15 min at room temperature. Cells accumulating at the interface (DC-enriched population; routinely comprising in excess of 70% DC) or in the pellet (DC-depleted population; routinely comprising less than 1% DC) were collected, washed once and resuspended in RPMI-FCS. The frequency of DC was assessed by direct morphological examination using interference microscopy and the number of DC per node were calculated.
Fluorescence analyses. Following topical exposure of mice to FITC, antigen-bearing (FTTC + ) cells in DC-enriched fractions of draining LNC were identified by microscopy and analytical flow cytometry (Kinnaird et al.. 1989; Cumberbatch and Kimber, 1990) . Cells were examined microscopically by reflected light fluorescence coupled with transmitted light to permit the simultaneous evaluation of fluorescent and nonfluorescent cells.
Cytometric analyses were performed using a FACScan flow cytometer (Becton-Dickinson UK Ltd., Oxford, UK) employing an excitation wavelength of 488 nm. Measurements were made of the frequency of fluorescent cells and of median fluorescence intensity.
Skin absorption. Percutaneous absorption of FITC from various application vehicles was measured in vitro using static glass diffusion cells according to a method described previously (Scott el al., 1986 (Scott el al., , 1992 Clowes et al., 1994) .
The dorsal and flank regions of mice were shaved ensuring that the skin was undamaged. Clipped areas of skin were excised, subcutaneous fat removed, and each sample of skin identified and stored at -20°C on aluminium foil until use. Samples of full-thickness flank skin were positioned in glass diffusion cells (Zeneca Engineering, Alderley Park, Cheshire, UK) forming a sealed horizontal membrane (exposed surface area of 0.79 cm 2 ) between the donor (outer) chamber and receptor (inner) chamber. Chambers were clamped and semi-immersed in a thermostatically controlled water bath to maintain skin temperature at 30°C. The receptor chamber was filled with a measured volume of 50% (v/v) ethanol in distilled water. Absorption of FITC was measured following application to the surface of the skin of 25 fiUcm 2 of a 1% concentration of the chemical in acetone or acetone supplemented with various concentrations of DBP. The diffusion cells were left unoccluded. After 48 hr the concentration of FITC which had permeated the skin into the receptor fluid was measured by gas chromatography.
To stabilize the analyte, 10 /il of 10 M sodium hydroxide was added to each 0.5-ml sample of receptor fluid. FITC was measured using an S5OD52 sphensorb column in 1:1 acetonitrile containing 2.5% acetic acid at a flow rate of 2 ml per minute. Detector wavelength was 273 nm and the injection volume 20 fj\. The amount of FITC absorbed was expressed as /ig/crrr or as a percentage of the applied dose. A minimum of six skin samples were used for each experimental group. Data are recorded as mean values ± standard error.
RESULTS
Lymph Node Cell Proliferation
The influence of DBP on FTTC-induced proliferative responses in draining lymph nodes was investigated. Topical application to mice of 1% FITC in acetone in the absence of DBP caused only a modest increase in proliferative activity compared with control lymph nodes draining the site of exposure to vehicle (acetone) alone. Two representative experiments are illustrated in Fig. 1 . Addition of DBP to FITC dissolved in acetone had a very marked effect on LNC proliferation, causing a dose-dependent increase in activity which was maximal with 10% DBP. At this concentration of the phthalate there was between a 5-fold and 10-fold increase in activity compared with FTTC applied in acetone alone (Fig. 1) . In the absence of FITC, application to mice of DBP dissolved in acetone was unable, at any concentration examined, to induce LNC proliferative responses (Fig. 1) .
The influence of DBP on FITC-induced LNC proliferative responses was found to be independent of the concentration of the skin sensitizer applied. Mice were exposed to various concentrations of FITC (0.25, 0.5, or 1%) in acetone or in acetone containing 10% DBP. As the results of the representative experiment illustrated in Fig. 2 reveal, at each application concentration of FITC examined, the addition of 10% DBP caused a very substantial increase in the vigor of LNC proliferative responses.
The influence of DBP on allergen-induced LNC proliferation was shown not to occur with another contact sensitizer. Thus, for instance, DBP failed at all concentrations to augment LNC proliferative responses induced in mice by exposure to 0.5% DNCB in acetone (Table 1) . Indeed, in this instance, application to mice of 0.5% DNCB in acetone containing 20% DBP caused a reduction in proliferative activity compared with responses observed following treatment with the same concentration of DNCB in acetone alone. The data in Table 1 confirm that, at all concentrations tested, DBP alone is unable to provoke proliferative responses by LNC. 
Dendritic Cell Accumulation in Draining Lvmph Nodes
Lymph node activation during the induction phase of contact sensitization and the stimulation of LNC proliferative responses are dependent upon the arrival within draining nodes of immunostimulatory antigen-bearing DC. The accumulation of DC in draining lymph nodes 18 hr following exposure of mice to 1% FITC in the presence and absence of 10% DBP was measured to determine whether changes in this phenomenon were associated with induced increases^ in LNC proliferation. Two representative experiments are illustrated in Fig. 3 . Consistent with previous investigations, unstimulated lymph nodes isolated from untreated BALB/c mice contained between 1000 and 3000 DC (Cumberbatch and Kimber, 1990; Cumberbatch et at., 1993) . Treatment of animals with acetone alone had no effect on DC numbers (Fig. 3) . Exposure to 1% FTTC in acetone caused an increase in the number of DC found within draining nodes. The same treatment, but with the addition of 10% DBP, also stimulated an increase in DC numbers comparable with, but usually slightly greater than, that observed following exposure to FITC in the absence of DBP. Administration to mice of acetone containing 10% DBP was without effect on DC accumulation (Fig. 3) . While DBP appeared to have only a modest influence on the total number of DC arriving in FITC-activated lymph nodes, its effect on the frequency of antigen-bearing (FITC + ) DC was considerably more profound. Only a relatively small percentage of DC isolated from lymph nodes draining the site of exposure to FITC in acetone alone had detectable levels of antigen as judged by fluorescence microscopy (2.5 and 3.6% in the experiments illustrated in Fig. 3 ). The proportion of antigen-bearing DC was increased very substantially when FITC was applied in acetone containing 10% DBP (19.0 and 20.9% in Fig. 3 ). Fluorescent cells were not found within the dendritic cellenriched fractions of lymph nodes from naive mice or from mice exposed to acetone or acetone containing 10% DBP (Fig. 3) . The characteristics of antigen-bearing DC isolated from the draining lymph nodes of mice exposed to 1 % FITC in either acetone alone or acetone containing 10% DBP are shown in Fig. 4 . These photomicrographs reflect the higher proportion of FTTC + cells found within the DC-enriched fraction of LNC prepared from mice treated with FITC in the presence of DBP.
The influence of DBP on the frequency of antigen-bearing DC found within draining lymph nodes 18 hr following topical sensitization to FITC was dose-dependent. In the experiment recorded in Table 2 , and consistent with the data illustrated in Fig. 3 , treatment of mice with 1% FTTC in the absence of DBP was associated with approximately 2% of lymph node DC displaying detectable antigen, as judged by fluorescence microscopy. Addition of 1% DBP caused a modest increase in the proportion of antigen-bearing DC. However, treatment with 1% FITC in acetone containing either 5 or 10% DBP resulted in a very substantial increase in the percentage of FTTC + DC (Table 2 ). Not only did DBP cause a significant increase in the proportion of lymph node DC bearing antigen, but it was found to be associated also with higher levels of cell-associated FITC. A representative flow cytometric analysis is shown in Fig. 5 . This reveals that the higher proportion of antigenbearing cells found within DC populations following exposure of mice to FITC in acetone containing 10% DBP was characterized also by a higher median level of fluorescence (Fig. 5b,i ) compared with antigen-bearing DC in nodes from animals exposed to FITC in the absence of DBP (Fig. 5b,ii) . Virtually no cell-associated fluorescence was measured in populations depleted of DC (Figs. 5a,i and 5a,ii) . The frequencies of FITC" 1 " cells bearing high levels of antigen in DC-enriched fractions as judged by flow cytometry were similar to those measured by fluorescence microscopy.
Percutaneous Absorption
The influence of DBP on the percutaneous absorption of FITC was measured in vitro using static diffusion cells. The results of a representative experiment are recorded in Table  3 . In the absence of DBP only 0.33% of the applied dose of FITC was absorbed through full-thickness mouse skin over a 48-hr period. Addition of 1 % DBP had no discernible influence, but 10% DBP caused a marked increase in the FIG. 4 . Antigen-bearing DC within the draining lymph nodes of mice exposed to 1% FITC: influence of DBP. Groups of mice (n = 10) were treated on the dorsum of both ears with 25 p\ of either 1% FITC in acetone (a) or 1% FITC in acetone containing 10% DBP (b). Dendritic cells were enriched from LNC by density gradient centnfugation. Microscopic identification of FITC + DC using reflected light fluorescence coupled with transmitted light (magnification (i), X20; (ii), X40).
absorption of FITC to 3.05% of the applied dose during 48 hr. When dissolved in acetone containing 20% DBP the absorption of FITC was reduced somewhat compared with that measured in the presence of 10% DBP (Table 3) .
DISCUSSION
The results reported here demonstrate that DBP is able to augment very substantially the vigor of FITC-induced LNC proliferative responses; these are considered to correlate closely with skin sensitizing potential (Kimberand Dearman, 1991) . Topical application of DBP alone failed to elicit any proliferative activity, so it can be concluded that this chemical lacks the potential to cause contact sensitization and that the increased activity observed is attributable to increased responsiveness to FTTC. The interpretation that DBP alone is unable to cause skin sensitization is in agreement with the verdict of Lehman, who concluded that DBP induced only very slight skin irritation, but no sensitization (Lehman, 1955) .
The stimulation of lymphocyte proliferation in draining nodes and the induction of contact sensitization is associated with and dependent upon the accumulation within the nodes of DC, a proportion of which bears antigen. The DC which arrive in lymph nodes following topical exposure to chemical allergens derive from epidermal Langerhans cells which are induced to leave the skin and migrate to draining nodes via afferent lymphatics (Kimber and Cumberbatch, 1992 tion is in turn facilitated by increased absorption of the chemical allergen into and through the skin remains unresolved. Although on the basis of in vitro studies described here, it appears that a higher proportion of the applied dose of FITC is absorbed in the presence of DBP, it is unclear whether this would influence materially the availability of the allergen in the viable epidermis. On the basis of these data the most judicious conclusion is that administration of FITC in the presence of DBP enhances substantially the ability of the allergen to provoke a cutaneous immune response. This enhanced responsiveness is undoubtedly attributable to an increased number of antigen-bearing DC reaching the draining lymph nodes, which may, in turn, be facilitated in part by more effective skin penetration of FTTC.
This and previous studies (Cumberbatch etai, 1993; Heylings et al., 1996) not only confirm that the formulation or vehicle in which a chemical is delivered to the skin can have an important influence on the development of sensitization, but also begin to define the mechanisms through which this can occur. The investigations described here indicate that, in principle, the formulation may affect sensitization secondary to an influence on the acquisition of antigen by Langerhans cells. It must be emphasized, however, that with other mixtures alternative processes may assume greater importance. Thus, it has been suggested previously that the ability of SLS to enhance lymph node responses to DNCB is secondary to increased migration of dendritic cells into draining nodes (Cumberbatch et al., 1993) . In other cases the central event may be altered skin penetration. It has been shown that when dissolved in acetone, DNCB provokes a more vigorous LNC proliferative response and is absorbed through mouse skin more rapidly than when propylene glycol is used as a vehicle (Heylings et al., 1996) . In the latter case there was no difference between the vehicles with respect to DNCB-induced DC accumulation in draining lymph nodes, although measurement of antigen acquisition by DC was not performed.
In conclusion, the available evidence suggests that components of a formulation, which themselves do not possess skin sensitizing activity, can influence in several ways the vigor of cutaneous immune responses induced by chemical allergens. Sensitization may be augmented by induced increases in the penetration of an allergen, its acquisition by Langerhans cells, and/or the efficiency of Langerhans cell migration and the accumulation of dendritic cells in draining lymph nodes. It can be predicted also that components of a formulation will exert variable influences on the efficiency of sensitization depending upon the nature of the inducing allergen. Thus, in the present investigations, DBP was found not to enhance responses induced by topical exposure of mice to DNCB. Further clarification of such mechanisms will provide a scientific basis for the rational design of safer formulations containing known or suspect contact allergens. In the meantime, however, the data suggest that the hazard assessment of new formulations and mixtures, and not just of active ingredients, would be prudent.
